Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-12-018656
Filing Date
2012-03-15
Accepted
2012-03-15 17:24:49
Documents
17
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a11-31848_110k.htm 10-K 1775950
2 EX-2.1 a11-31848_1ex2d1.htm EX-2.1 21198
3 EX-3.1 a11-31848_1ex3d1.htm EX-3.1 28182
4 EX-3.2 a11-31848_1ex3d2.htm EX-3.2 91581
5 EX-10.8 a11-31848_1ex10d8.htm EX-10.8 85264
6 EX-23 a11-31848_1ex23.htm EX-23 2745
7 EX-31.1 a11-31848_1ex31d1.htm EX-31.1 9829
8 EX-31.2 a11-31848_1ex31d2.htm EX-31.2 10195
9 EX-32.1 a11-31848_1ex32d1.htm EX-32.1 6570
10 EX-32.2 a11-31848_1ex32d2.htm EX-32.2 6206
17 GRAPHIC g318481bgi001.jpg GRAPHIC 41431
  Complete submission text file 0001104659-12-018656.txt   5277450

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE DOCUMENT sgyp-20111231.xml EX-101.INS 633104
12 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgyp-20111231.xsd EX-101.SCH 21267
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sgyp-20111231_cal.xml EX-101.CAL 54184
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sgyp-20111231_def.xml EX-101.DEF 84508
15 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT sgyp-20111231_lab.xml EX-101.LAB 290412
16 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgyp-20111231_pre.xml EX-101.PRE 128764
Mailing Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE SUITE 1609 NEW YORK NY 10170 212-297-0010
SYNERGY PHARMACEUTICALS, INC. (Filer) CIK: 0001347613 (see all company filings)

EIN.: 203823853 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35268 | Film No.: 12695057
SIC: 2834 Pharmaceutical Preparations